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Analysis of single-cell RNA-sequencing (scRNA-seq) data is plagued by dropouts, zero 
counts for mRNA transcripts due to low mRNA in individual cells and inefficient mRNA 
capture. Dropouts are traditionally treated as an error to be corrected through normalization 
while performing unsupervised clustering of single cells based on highly expressed, variable 
transcripts. A novel algorithm, co-occurrence clustering, treats dropouts as a signal and binarizes 
scRNA-seq data for cell clustering, producing the same clusters as Seurat.  
Previous application of Seurat to single nuclear RNA-sequencing (snRNA-seq) data 
taken from the prefrontal cortex (PFC) and anterior cingulate cortex (ACC) of patients with 
autism spectrum disorder (ASD) found no difference in clusters between brain regions. This 
seems at odds with literature suggesting tissue-specific emergence of co-expression networks 
and regional specialization in the brain. We applied co-occurrence clustering to ASD samples to 
parse interregional heterogeneity between the PFC and ACC and identify novel cell clusters.  
Introduction 
Autism spectrum disorder (ASD) affects 1.9% of children in the United States. Complex 
gene-environment interactions give rise to ASD, and recent studies suggest that at least 50% of 
the risk of developing ASD is attributable to genetic variation [1]. Despite this, ASD and other 
psychiatric disorders are highly heterogeneous, which makes identification of important genetic 
risk factors difficult. Historically, approaches involving genome-wide association studies 
(GWAS) to identify common genetic variants in the form of single-nucleotide polymorphisms 
(SNPs) have been successful [2]. However, common genetic variants individually explain just a 
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small amount of the variance in liability, and cumulatively genome-wide significant SNPS 
account for only 1-2% of observed variance [3]. As such, no singular genetic variant can be 
attributed to ASD. Nevertheless, from the array of genes identified with relevance to ASD,  gene 
networks have been constructed that show convergence on neuronal development, modulation, 
and intracellular transcriptional mechanisms.  
Gene expression profiling by RNA-seq can be used to identify cell types associated with 
ASD, offering an additional layer of granularity. Indeed, evidence of convergent dysregulation 
from cell types has been revealed in the first of its kind study using single-nucleus RNA 
sequencing (snRNA-seq) [4]. Postmortem samples of ASD and control patients were taken from 
the Anterior Cingulate Cortex (ACC) and Prefrontal Cortex (PFC) and processed for nuclei 
isolation and snRNA-seq using the 10x Genomics platform. Unbiased clustering of the ACC and 
PFC together and separately resulted in the identification of the same cell types. This appears to 
be at odds with literature suggesting tissue-specific co-expression networks emerge 
spatiotemporally from different cell types [5]. Recent advances in neural circuits using the 
research domain criteria (RDoC) shows that the PFC and ACC serve together and separately in 
mood and anxiety disorders [6]. Significant genetic overlap with ASD and hierarchical 
transcriptomic specialization across brain regions suggest that some distinction should be 
apparent between the PFC and ACC [7].  
Potential explanations for why this was not captured in the original study include sample 
size and dropout events. Dropout events are a limitation of single-cell RNA-seq studies, arising 
from low mRNA in individual cells and inefficient mRNA capture [8]. In existing scRNA-seq 
methods, feature selection is typically performed only once through principal component 
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analysis of highly variable genes. In this pipeline, dropouts are filtered out and the remaining 
transcript abundance counts are normalized such that only highly expressed variable genes are 
considered. A new co-occurrence clustering algorithm developed by Dr. Peng Qiu at Georgia 
Tech treats these dropouts as a useful signal instead of noise to identify additional cell types. 
Furthermore, feature selection is re-visited for each iteration of clustering to characterize the 
heterogeneity of cells under consideration. An initial assessment of this approach shows that 
co-occurrence clustering produces more clusters than previous analyses of the same datasets. 
This suggests that different bioinformatic strategies may be optimal for analyzing cell 
populations with varying levels of heterogeneity, such as those found in the PFC and ACC.  
To further understand region-specific cellular heterogeneity in ASD, this study will 
examine how dysregulation of the ACC and PFC contribute to ASD through the application of 
co-occurence clustering to scRNA-seq samples. It is predicted that this method will identify 
additional cell types implicated in tissue-specific gene networks through subsequent differential 
gene expression analyses of the ACC and PFC. This novel approach seeks to further characterize 
the heterogeneous nature of ASD, identifying novel dysregulated pathways for therapeutic 
intervention and diagnosis. 
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Clinical heterogeneity is a hallmark of autism spectrum disorder (ASD) as reflected in the 
current Diagnostic and Statistical Manual for Mental Disorders (DSM-5). Likewise, recent 
research initiatives to detect the biological basis of psychiatric disorders have revealed 
significant genetic heterogeneity that underpins phenotypic expression[1]. However, the path 
from gene to behavior is complex and arduous. Network-based approaches seek to integrate the 
common and rare genetic variants involved in autism and identify cellular pathways [2]. Recent 
advances in single-cell RNA sequencing (scRNA-seq) have introduced a new level of granularity 
in this approach. Unbiased clustering of expression leads to the identification of cell types 
involved in disease pathogenesis. Subsequent differential gene expression analysis of cell types 
and gene ontology analysis constructs gene networks that provide new insights into ASD through 
the identification of affected cellular pathways. Despite these advances, dropout reads from 
scRNA-seq data acquisition and increasing evidence of region-specific transcriptomic profiles in 
the brain pose barriers, and present opportunities for further research [3,4]. To address this, a 
novel co-occurrence clustering algorithm has been developed that uses dropout reads as a signal 
[5]. This approach may detect intra-region heterogeneity with greater precision than traditional 
methods, potentially yielding new insight into therapeutic targets for ASD.  
An overarching goal of current research is to define ASD by its genetic components. At 
least 50% of the risk of developing ASD is attributable to genetic variation [7]. Hundreds of 
genes are likely related to autism. Unfortunately, genome-wide association studies (GWAS) have 
failed to identify single variants at genome-wide significance [6]. It is only within the past 
several years that sample sizes have grown large enough to detect the minuscule effect sizes of 
10 
pathogenic variants on the disease itself. One explanation for why GWAS has failed to identify 
additional variants lies in the focus of GWAS on susceptibility loci, which ignores other variants 
that are not causative alone [8]. Connections between genes and behaviors are further 
complicated by how etiology is shared across multiple complex disorders. Indeed, results from 
the Psychiatric Genomics Consortium show a significant overlap between variants associated 
with schizophrenia and autism [8]. Furthermore, epigenetic factors can have a profound impact 
on the transcriptome of an organism. Epigenetic factors may be causative in of themselves but 
may also influence the expression of risk genes to modulate disease state [7,8]. In the journey 
from gene to behavior, gene-gene and gene-environment interactions result in hierarchical 
disease manifestations across the genome, transcriptome, proteome, etc. It is thus imperative to 
explore each of these -omic analyses both independently and jointly, in order to uncover how 
ASD behavior emerges from lower biological levels.  
 Co-occurence clustering of dropout reads may yield an additional level of precision by 
detecting layers of complexity to neural circuit composition that are not apparent from studies of 
only highly abundant genes. Large-scale neural circuits serve as endophenotypes and 
theoretically lie closer to the underlying biology of ASD. The central idea is that neural circuits 
compute behavioral actions and that this computation is heavily influenced by the physical 
architecture of neuronal connectivity encoded by genetic variants [9]. One example of a 
large-scale neural circuit is negative valence, which interprets the intrinsic averseness of 
environmental stimuli [9]. Negative valence systems involve connectivity and activation between 
the anterior cingulate cortex, insula, and amygdala. Because neural circuits define physical 
regions of the brain, studying which variants are associated with altered architecture should yield 
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dysfunctional pathways. However, several well-powered genetic studies of psychiatric disorders 
have failed to demonstrate more than a handful of correlations between genetic variants and 
structural imaging traits derived from fMRI scans [10]. A likely explanation for this is that 
pathogenic variants do not significantly alter gross brain structure, but act at the cellular or 
subcellular level. One line of evidence to support this hypothesis comes from the study of 
transcriptomic specialization across the human cortex. Hierarchical transcript gradients define an 
axis shared by transcriptomic and anatomical architecture of the cortex [11]. Transcriptomic 
diversity influences microscale properties that contribute to macroscale function. With the advent 
of single-cell RNA sequencing, it is now possible to characterize individual cell types within 
micro and macro neural circuits that contribute to ASD.  
One of the advantages of co-occurence clustering using single-cell RNA is the level of 
precision it yields compared to traditional bulk-brain sequencing. Single-cell RNA sequencing 
has introduced an unprecedented level of granularity in identifying how neuropsychiatric 
conditions affect individual cell types [12]. Single-nucleus RNA sequencing analysis identified 
that synaptic signaling of upper-layer excitatory neurons and microglia are preferentially affected 
in autism [13]. However, few differentially expressed genes were observed compared to 
bulk-brains sequencing and even fewer between regions sampled (prefrontal cortex and anterior 
cingulate cortex). One potential explanation is due to the infamous issue of dropouts. Limitations 
of scRNA-seq include low capture efficiency and sequence coverage that results in a higher level 
of noise than bulk RNA-seq data [14]. Dropouts occur when no transcript is captured. This issue 
is particularly pernicious in regions of high cell-to-cell heterogeneity, where dropout events 
increase. Dropouts are typically handled through normalization when focusing on highly variable 
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genes (e.g. Seurat) or used to perform feature selection through methods like M3Drop [14-16]. A 
new co-occurrence clustering algorithm developed by Dr. Qiu uses dropouts as a useful signal 
similar to M3Drop [17,18]. Unlike M3Drop, however, feature selection is re-visited for each 
iteration of clustering to produce more clusters than traditional methods like Seurat. Because of 
the method’s ability to handle varying levels of heterogeneity, co-occurrence clustering may be 
particularly well-suited to the transcriptomic diversity and specialization of neural circuits. As 
such, the application of co-occurrence clustering to characterize intraregional heterogeneity in 
ASD samples should detect novel pathways that are otherwise obscured by focusing on highly 
expressed, variable genes.  
In sum, genetic variation affects multiple levels of biology, at different developmental 
periods, within certain cell types, altering the physical structure of neural circuits, affecting how 
circuits perform computations, and producing canonical behavioral symptoms of ASD [9,10]. By 
researching how ASD affects individual cell types within neural circuit regions, it may be 
possible to identify new pathways for disease treatment and identification. Crucial to this 
endeavor will be how to handle dropouts that influence data quality and, ultimately, the accuracy 
of implicated pathways. Co-occurrence clustering and similar methods that treat dropouts as a 
useful signal may complement or outperform existing strategies that focus on highly expressed 
variable genes. The unprecedented precision these methods offer into how ASD emerges at the 
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snRNA-seq data from ASD patients was obtained from a previous study conducted by 
Velmeshev et al and available at the SRA accession PRJNA434002. Information about nuclei 
extraction and quality control are available in Velmeshev’s supplementary materials. Samples 
were split into groups based on the cortical region they were obtained from (PFC or ACC) and 
phenotype (ASD or control).  
Library demultiplexing, fastq file generation, read alignments, and unique molecular 
identifiers (UMI) quantification was achieved using CellRanger software v 1.3.1 and default 
parameters. Samples were aligned against the pre-mRNA reference file (ENSEMBL GRCh38) to 
capture introns. After processing by CellRanger, we performed two separate methods of 
dimensionality reduction, clustering, and visualization through a MATLAB-based 
implementation.  
Samples from the PFC and ACC for ASD and control patients are run through the 
MATLAB-based co-occurrence clustering algorithm to produce cell clustering results. A full 
description of co-occurrence clustering is provided by Qiu on biorxiv 
(​https://www.biorxiv.org/content/10.1101/468025v2.full.pdf+html​). For the purposes of this 
paper, we will provide a brief summary of the methodology. 
First, the algorithm binarizes the scRNA-seq count matrix and evaluates a statistical 
measure for co-occurrence between each pair of genes through the Jaccard index. The graph is 
then partitioned into gene clusters using the Louvain algorithm, leaving gene clusters with high 
co-occurrence that represent pathways for major groups of cell types in heterogeneous 
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populations. Percentages of detected genes in each cell are used to build a cell-cell graph. 
Community detection is then applied to further partition the graph into smaller clusters in an 
iterative manner. Cluster validity is assessed by mean difference and mean ratios. Similar 
clusters are merged while heterogeneous ones continue to be partitioned into subclusters.  
After cell clustering and visualization with co-occurrence clustering, the same samples 
are clustered using a MATLAB-based Seurat implementation. A confusion heatmap compares 
the cell clusters generated by co-occurrence clustering and Seurat to demonstrate the difference 
in the algorithms’ ability to partition heterogeneity in cortical samples.  
Results 
One sample clustering 
 
Application of co-occurrence clustering to sn-RNAseq data gathered from the PFC of one ASD 
patient produced 34 cell clusters (Fig. 1), and Seurat identified 15 (Fig. 2). 
 




Figure  2​: Seurat clustering and tSNE representation of one ASD PFC sample 
Aggregate Sample Clustering 
Co-occurrence clustering was performed on aggregate samples from the ACC and PFC of 
patients with ASD. We found 119 robust cell clusters in the PFC and 98 clusters in the ACC. 
Furthermore, 142 gene clusters were found in the PFC compared to 125 clusters in the ACC.  
 
Figure 3: ​Co-occurence clustering of ASD PFC samples 
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Figure 4: ​Co-occurence clustering of ASD ACC samples 
 
Seurat Clustering  
Seurat with tSNE for dimensionality reduction was used to cluster cells within the PFC 
(Figure 5) and ACC (Figure 6), identifying 20 clusters for both regions. A MATLAB-based 
implementation of Seurat, as part of the co-occurence clustering pipeline, was used to perform 
dimensionality reduction and generate respective tSNE plots.  
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Figure 5: PFC Seurat clusters 
 







Our results demonstrate the utility of co-occurrence clustering for parsing interregional 
heterogeneity in the brain. Within a single sample of the PFC from one ASD patient, 34 cell 
clusters were identified by co-occurrence clustering (Fig. 1) compared to 15 by Seurat (Fig. 2). 
The high ratio of co-occurrence to Seurat clusters observed in a single sample generalizes to 
aggregate samples of the PFC and ACC. Seurat only identified 20 cell clusters for both regions 
(Fig. 5 and 6), whereas co-occurrence clustering produced 119 clusters in the PFC (Fig. 3) and 
98 clusters in the ACC (Fig. 4). The identification of the same number of cell clusters by Seurat 
is consistent with prior analysis by Velmeshev et al [1]. The 5x difference in cluster count 
between Seurat and co-occurrence clustering confirms our initial hypothesis that co-occurrence, 
owing to its use of dropouts and iterative feature selection, would produce more clusters than 
Seurat. It is worth noting, however, that this is the first application of co-occurrence clustering to 
sn-RNAseq data. Therefore, it is possible that the high cluster ratio is, in part, a technical error 
for not adjusting parameters of co-occurrence clustering to the new data type and the pre-mRNA 
reference.  
Co-occurrence clustering not only identified more clusters than Seurat, but produced a 
marked difference in cluster count between brain regions. Our observed discrepancy between 
cell clusters found in the PFC and ACC (119, 98 respectively) matches the disparity in gross 
brain volume between the two regions [2]. The larger volume of the PFC presents the 
opportunity for greater intraregional specialization, and thus more cell types and subtypes, 
compared to the ACC. Furthermore, additional studies have highlighted the region-dependent 
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emergence and specialization of gene co-expression networks in the brain [3, 4]. The difference 
in cluster count between the ACC and PFC from co-occurrence clustering supports the existence 
of region-specific dysregulation in gene co-expression networks in the context of ASD.  
In sum, we have demonstrated the utility of co-occurrence clustering for snRNA-seq data, 
identified novel cell clusters implicated in ASD, and reported the first-known delineation of 
interregional heterogeneity between PFC and ACC clusters from our data set. Our results show 
that dropouts, typically viewed as a source of technical error, can be used as a valuable signal to 
analyze highly heterogeneous regions of the brain. Further analysis of identified cell clusters may 
yield novel dysfunctional pathways unique to our sampled brain regions and improve our 
understanding of the biological emergence of ASD.  
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